Volume 20, Number 1—January 2014
Dispatch
Rapidly Fatal Hemorrhagic Pneumonia and Group A Streptococcus Serotype M1
Table
Primers used for identification of virulence genes by PCR for group C Streptococcus isolates*
Gene | Primer name† | Primer sequence, 5′→3′ | Amplicon size, bp |
---|---|---|---|
Slo | MS442 | GGTAACCTTGTTACTGCTAATGCTGA | 400 |
MS443 | TAATGGAAATATCGACTGGTGTAGTG‡ | 400 | |
speA | speA-fw | CTCAACAAGACCCCGATCCAAG | 500 |
speA-rew | ATTTAGAAGGTCCATTAGTATATAGTTGC‡ | 500 | |
speB | MS384 | GGCATGTCCGCCTACTTTACCGA | 800 |
MS385 | CAGGTGCACGAAGCGCAGAAG‡ | 800 | |
speC | MS410 | TACTGATTTCTACTATTTCACCTATCATC | 447 |
MS411 | TCTGATTTTAAAGTCAATTTCCTGG‡ | 447 | |
speG | MS412 | GCTATGGAAGTCAATTAGCTTATGCAG | 448 |
MS413 | CCGATGTATAACGCGATTCCGA‡ | 448 | |
speI | speI-up | GGTCCGCCATTTTCAGGTAGTTT | 516 |
speI-rew | ACGCATACGAAATCATACCAGTAG‡ | 516 | |
speJ | MS414 | CACTCCTTGTACTAGATGAGGTTGC | 508 |
MS415 | ACGCATACGAAATCATACCAGTAG‡ | 508 | |
sagBC | sagBC-fw | GCAGCTAGTTGCTCAACATTTAATG | 600 |
sagBC | sagBC-rew | CATAGGCAGTCGCCTGATTCC‡ | 600 |
prtF | MS400 | CGGAGTATCAGTAGGACATGCGGA | 882 |
prtF | MS401 | CTCCCACCAACATTGCTTAATCCA‡ | 882 |
PAM | PAM-fw | GCAGACGACGCTAGAAATGAAGTA | 900 |
PAM-rew | CCTGCTTGTGGTGCTTGACCTTTAC‡ | 900 | |
Sof | MS402 | ATGCCTGGTTGGGTATCTTCGGT | 406 |
MS403 | AGAGAACAAAACGTTCTGCGCCTA‡ | 406 | |
Ssa | ssa-fw | GTAGTCAGCCTGACCCTACTCCAGAAC | 621 |
ssa-rew | ACTGATCAAATATTGCTGCAGGTGC‡ | 621 | |
sda1 | MS431 | GGGTCTATAAGAAAAGTGGGCAAAG | 439 |
MS432 | TGATCGTAAAGGTGGGATGCAGTA‡ | 439 |
*slo, streptolysin O; sagA/BC, streptolysin S-associated gene A protein; smeZ-2 mitogenic exotoxin Z; speA, streptococcal pyrogenic toxin A; speB, streptococcal cysteine protease; speC, streptococcal pyrogenic toxin C; speG, streptococcal pyrogenic toxin G; speI, streptococcal pyrogenic toxin I; speJ; streptococcal pyrogenic toxin J; prtF, fibronectin-binding protein; PAM, plasminogen-binding protein; sof serum opacity factor; ssa streptococcal superantigen; sda1, streptodornase D.
†Primers indicated in boldface were created with the VectorNT program (Invitrogen, Carlsbad, CA, USA). Other primers were described by Santagati et al. (11).
‡Reverse primers.
References
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–94. DOIPubMedGoogle Scholar
- Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72:1213–27. DOIPubMedGoogle Scholar
- Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011;9:724–36. DOIPubMedGoogle Scholar
- Henningham A, Barnett TC, Maamary PG, Walker MJ. Pathogenesis of group A streptococcal infections. Discov Med. 2012;13:329–42 .PubMedGoogle Scholar
- Friães A, Pinto FR, Silva-Costa C, Ramirez M, Melo-Cristino J. Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol. 2012;12:280. DOIPubMedGoogle Scholar
- Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill. 2005;10:179–84 .PubMedGoogle Scholar
- Turner CE, Dryden M, Holden MT, Davies FJ, Lawrenson RA, Farzaneh L, Molecular analysis of an outbreak of lethal postpartum sepsis caused by Streptococcus pyogenes. J Clin Microbiol. 2013;51:2089–95. DOIPubMedGoogle Scholar
- Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis. 2005;192:771–82. DOIPubMedGoogle Scholar
- Herwald H, Cramer H, Mörgelin M, Russell W, Sollenberg U, Norrby-Teglund A, M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116:367–79. DOIPubMedGoogle Scholar
- Uchiyama S, Andreoni F, Schuepbach RA, Nizet V, Zinkernagel AS. DNase Sda1 allows invasive M1T1 group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog. 2012;8:e1002736. DOIPubMedGoogle Scholar
- Santagati M, Scillato M, Patane F, Aiello C, Stefani S. Bacteriocin-producing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol Med Microbiol. 2012;65:23–31. DOIPubMedGoogle Scholar
- Lassalle S, Hofman V, Butori C, Sicard D, Hofman P. Histological diagnosis of lung bacterial necrotizing infections: a study of four fulminant cases. Ann Pathol. 2005;25:349–56. DOIPubMedGoogle Scholar
- Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:981–5. DOIPubMedGoogle Scholar
- Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun. 2000;68:6362–9 . DOIPubMedGoogle Scholar
1These authors contributed equally to this article.